A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the second most frequent cause of ESRD in the first two decades of life. Effective treatment is lacking. First insights into disease mechanisms came from identification of single-gene causes of SRNS. However, the frequency of single-gene causation and its age distribution in large cohorts are unknown. We performed exon sequencing of NPHS2 and WT1 for 1783 unrelated, international families with SRNS. We then examined all patients by microfluidic multiplex PCR and next-generation sequencing for all 27 genes known to cause SRNS if mutated. We detected a single-gene cause in 29.5% (526 of 1783) of families with SRNS that manifested before 25 years of age. The fraction of families in whom a single-gene cause was identified inversely correlated with age of onset. Within clinically relevant age groups, the fraction of families with detection of the single-gene cause was as follows: onset in the first 3 months of life (69.4%), between 4 and 12 months old (49.7%), between 1 and 6 years old (25.3%), between 7 and 12 years old (17.8%), and between 13 and 18 years old (10.8%). For PLCE1, specific mutations correlated with age of onset. Notably, 1% of individuals carried mutations in genes that function within the coenzyme Q10 biosynthesis pathway, suggesting that SRNS may be treatable in these individuals. Our study results should facilitate molecular genetic diagnostics of SRNS, etiologic classification for therapeutic studies, generation of genotype-phenotype correlations, and the identification of individuals in whom a targeted treatment for SRNS may be available.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among these were many gene products currently known to be associated with hereditary nephrotic syndrome (Sadowski et al., 2015).”
From A Multi-layered Quantitative In Vivo Expression Atlas of the Podocyte Unravels Kidney Disease Candidate Genes (2018) · cites this paper as Sadowski et al., 2015
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boute, N., Gribouval, O., Roselli, S., Benessy, F., Lee, H., Fuchshuber, A., Dahan, K., Gubler, M.-C., Niaudet, P., & Antignac, C. (2000) · Nature Genetics · doi:10.1038/74166 · Cited by 1,444
The spectrum of podocytopathies: A unifying view of glomerular diseases
Wiggins, R.-C. (2007) · Kidney International · doi:10.1038/sj.ki.5002222 · Cited by 757
Hinkes, B., Wiggins, R. C., Gbadegesin, R., Vlangos, C. N., Seelow, D., Nürnberg, G., Garg, P., Verma, R., Chaib, H., Hoskins, B. E., et al. (2006) · Nature Genetics · doi:10.1038/ng1918 · Cited by 569
Self-citationSmith, J. M., Stablein, D. M., Munoz, R., Hebert, D., & McDonald, R. A. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00704.x · Cited by 479
Hinkes, B. G., Mucha, B., Vlangos, C. N., Gbadegesin, R., Liu, J., Hasselbacher, K., Hangan, D., Ozaltin, F., Zenker, M., Hildebrandt, F., et al. (2007) · Pediatrics · doi:10.1542/peds.2006-2164 · Cited by 444
Self-citationRuf, R. G., Lichtenberger, A., Karle, S. M., Haas, J. P., Anacleto, F. E., Schultheiss, M., Zalewski, I., Imm, A., Ruf, E.-M., Mucha, B., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000113552.59155.72 · Cited by 417
Self-citationCOQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness
Heeringa, S. F., Chernin, G., Chaki, M., Zhou, W., Sloan, A. J., Ji, Z., Xie, L. X., Salviati, L., Hurd, T. W., Vega-Warner, V., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45693 · Cited by 398
Self-citationWeber, S., Gribouval, O., Esquivel, E. L., Morinière, V., Tête, M.-J., Legendre, C., Niaudet, P., & Antignac, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00776.x · Cited by 375
ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption
Ashraf, S., Gee, H. Y., Woerner, S., Xie, L. X., Vega-Warner, V., Lovric, S., Fang, H., Song, X., Cattran, D. C., Avila-Casado, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci69000 · Cited by 341
Self-citationGetting a foothold in nephrotic syndrome
Somlo, S., & Mundel, P. (2000) · Nature Genetics · doi:10.1038/74139 · Cited by 271
Cited by
Items 201–300 of 651
Autoimmunity in Focal Segmental Glomerulosclerosis: A Long-Standing Yet Elusive Association
Podestà, M. A., & Ponticelli, C. E. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.604961 · Cited by 25
The causes and consequences of paediatric kidney disease on adult nephrology care
Pepper, R. J., & Trompeter, R. S. (2021) · Pediatric Nephrology · doi:10.1007/s00467-021-05182-w · Cited by 21
Genotype-Phenotype Correlation in WT1 Exon 8 to 9 Missense Variants
Nagano, C., Takaoka, Y., Kamei, K., Hamada, R., Ichikawa, D., Tanaka, K., Aoto, Y., Ishiko, S., Rossanti, R., Sakakibara, N., et al. (2021) · Kidney International Reports · doi:10.1016/j.ekir.2021.05.009 · Cited by 22
“WT1 gene variants also cause various types of glomerulonephritis globally.(18,19) Especially in Japan, the most common”
BackgroundPodocyte-specific Crb2 knockout mice develop focal segmental glomerulosclerosis
Tanoue, A., Katayama, K., Ito, Y., Joh, K., Toda, M., Yasuma, T., D’Alessandro‐Gabazza, C. N., Kawachi, H., Yan, K., Ito, M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-00159-z · Cited by 22
Morello, W., Proverbio, E., Puccio, G., & Montini, G. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.10.030 · Cited by 23
“ved 6 August 2022; revised 26 October 2022; accepted 31 er 2022; published online 8 November 2022 The diffusion of a widespread and reliable genetic testing has allowed for the identification of causative genetic mutations in one-third of SRNS cases.(6) In a multicenter national study of 101 children with SRNS transpl…”
BackgroundGenetics of congenital and infantile nephrotic syndrome
Sharief, S. N., Hefni, N. A., Alzahrani, W. A., Nazer, I. I., Bayazeed, M. A., Alhasan, K. A., Safdar, O. Y., El-Desoky, S. M., & Kari, J. A. (2019) · World Journal of Pediatrics · doi:10.1007/s12519-018-00224-0 · Cited by 22
Self-citationLi, Q., Gulati, A., Lemaire, M. J., Nottoli, T., Bale, A. E., & Tufró, A. (2021) · Kidney International · doi:10.1016/j.kint.2020.12.022 · Cited by 22
Early-onset of ADCK4 glomerulopathy with renal failure: a case report
Lolin, K., Chiodini, B., Hennaut, E., Adams, B., Dahan, K., & Ismaïli, K. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0392-9 · Cited by 21
Anígilájé, E. A., & Olutola, A. (2019) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s193874 · Cited by 22
“The pathogenesis of primary FSGS probably involves a circulating factor.75–79 While it is unclear what may be the circulating factor, possible candidates include CLCF1, ApoA1b (an isoform of ApoA1), anti-CD40 antibody, and suPAR.75–79 Widespread foot-process effacement on electron microscopy characterizes podocyte inj…”
BackgroundInfluentialBraunisch, M. C., Riedhammer, K. M., Herr, P.-M., Draut, S., Günthner, R., Wagner, M., Weidenbusch, M. J., Lungu, A. C., Alhaddad, B., Renders, L., et al. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-00719-3 · Cited by 22
Monogenic Causes of Proteinuria in Children
Çil, O., & Perwad, F. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00055 · Cited by 25
“Similar observations were made in another large international study of SRNS patients (11); in 1,783 unrelated families with SRNS, a singlegene mutation was identified in 29.”
BackgroundResultC-terminal oligomerization of podocin mediates interallelic interactions
Stráner, P., Balogh, E., Schay, G., Arrondel, C., Mikó, Á., L’Auné, G., Benmerah, A., Perczel, A., Menyhárd, D. K., Antignac, C., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.04.008 · Cited by 22
The genetics of steroid-resistant nephrotic syndrome in children
Dorval, G., Servais, A., & Boyer, O. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa221 · Cited by 20
Management of Steroid-Resistant Nephrotic Syndrome in Children
Sachdeva, S., Khan, S., Davalos, C., Avanthika, C., Jhaveri, S., Babu, A., Patterson, D., & Yamani, A. J. (2021) · Cureus · doi:10.7759/cureus.19363 · Cited by 24
“They have identified that hereditary podocytopathies are responsible for up to 30% of children with SRNS by genetic screening [12].”
BackgroundHarshman, L. A., Bartosh, S. M., & Engen, R. M. (2022) · Pediatric Transplantation · doi:10.1111/petr.14307 · Cited by 22
Genetic testing in focal segmental glomerulosclerosis: in whom and when?
Tato, A., Carrera, N., García-Murias, M., Shabaka, A., Ávila, A., Mora, M. T. M., Rabasco, C., Soto, K., Álvarez, F. J. D. L. P., Lorente, L. F., et al. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad193 · Cited by 20
Wilson, P. C., Love-Gregory, L. D., Corliss, M. M., McNulty, S. N., Heusel, J. W., & Gaut, J. P. (2020) · Kidney360 · doi:10.34067/kid.0001342020 · Cited by 23
The Evolving Role of Diagnostic Genomics in Kidney Transplantation
Soraru, J., Chakera, A., Isbel, N. M., Mallawaarachichi, A., Rogers, N. M., Trnka, P., Patel, C., & Mallett, A. J. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.05.019 · Cited by 20
“5% of all allcomers in a worldwide cohort of patients who presented with SRNS before age 25 years having an identifiable mutation.(78) It is recommended that those who have presented with SRNS or phenotypes compatible with such a diagnosis, particularly at younger ages of onset, are offered genetic testing before rena…”
BackgroundManikandan, V., Anushkkaran, P., Hwang, I. S., Song, M. S., Kumar, M., Chae, W., Lee, H.-H., Ryu, J., Mahadik, M. A., & Jang, J. S. (2023) · Chemosphere · doi:10.1016/j.chemosphere.2023.139255 · Cited by 19
Campbell, K. N., Gesualdo, L., Murphy, E., Rheault, M. N., Srivastava, T., Tesař, V., Komers, R., & Trachtman, H. (2024) · Kidney Medicine · doi:10.1016/j.xkme.2024.100833 · Cited by 22
“Multiple causes lead to FSGS lesions, which can be categorized as primary, 8,9 genetic, 10,11 secondary, 1,9 and unknown etiology.”
Evaluation for genetic disease in kidney transplant candidates: A practice resource
Ames, E. G., Anand, P. M., Bekheirnia, M. R., Doshi, M. D., Ters, M. E., Freese, M. E., Gbadegesin, R., Guay‐Woodford, L. M., Java, A., Ranch, D., et al. (2024) · American Journal of Transplantation · doi:10.1016/j.ajt.2024.10.019 · Cited by 20
A novel ADCK4 mutation in a Chinese family with ADCK4-Associated glomerulopathy
Yang, J., Yang, Y., & Hu, Z. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.10.102 · Cited by 19
Siji, A., Karthik, K. N., Pardeshi, V. C., Hari, P., & Vasudevan, A. (2018) · BMC Medical Genetics · doi:10.1186/s12881-018-0714-6 · Cited by 19
Jayasinghe, K., Stark, Z., Patel, C., Mallawaarachchi, A. C., McCarthy, H. J., Faull, R., Chakera, A., Sundaram, M., Jose, M., Kerr, P. G., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-029541 · Cited by 19
“Until now, the diagnostic utility of genomic testing has been assessed in a small number of patients or in a research context.(29) 30 In addition, while studies which perform genomic sequencing in larger cohorts(6) 31 are emerging, detailed phenotypic information is not being collected and there remains a paucity of d…”
BackgroundCharting a TRP to Novel Therapeutic Destinations for Kidney Diseases
Pablo, J. L., & Greka, A. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.001 · Cited by 18
“In all cases for which biopsy data was available, individuals with identified TRPC6 mutations displayed FSGS [21].”
BackgroundLook Alike, Sound Alike: Phenocopies in Steroid-Resistant Nephrotic Syndrome
Becherucci, F., Landini, S., Cirillo, L., Mazzinghi, B., & Romagnani, P. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228363 · Cited by 19
“with NGS and despite the application in large cohorts of patients [26], the diagnostic rate of genetic forms of SRNS did not significantly improve over 30% even after an impressive increase in the number of podocytopathy genes analyzed by NGS (gene panels and WES) (Figure 1).”
BackgroundWT1 and NPHS2 gene mutation analysis and clinical management of steroid-resistant nephrotic syndrome
Ramanathan, A. S. K., Vijayan, M., Rajagopal, S., Padmaraj, R., & Senguttuvan, P. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2889-5 · Cited by 19
“In the last two decades, advancement of molecular study has identified new podocyte genes NPHS1-Nephrin, NPHS2-Podocin, WT1Wilms’ Tumor-1, and 25 known podocyte genes [2].”
BackgroundUdagawa, T., Jo, T., Yanagihara, T., Shimizu, A., Mitsui, J., Tsuji, S., Morishita, S., Onai, R., Miura, K., Kanda, S., et al. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3549-4 · Cited by 19
What are we missing in the clinical trials of focal segmental glomerulosclerosis?
Zand, L., Glassock, R. J., Vriese, A. S. D., Sethi, S. M., & Fervenza, F. C. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw324 · Cited by 18
Neuroimaging in Primary Coenzyme-Q10-Deficiency Disorders
Münch, J., Prasuhn, J., Laugwitz, L., Fung, C., Chung, B. H., Bellusci, M., Mayatepek, E., Klee, D., & Distelmaier, F. (2023) · Antioxidants · doi:10.3390/antiox12030718 · Cited by 21
Ueda, H., Tran, Q. T. H., Tran, L., Higasa, K., Ikeda, Y., Kondo, N., Hashiyada, M., Sato, C., Sato, Y., Ashida, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-38588-7 · Cited by 19
“Based on (1) only a few INF2 mutations that cause CMT alone and (2) the fact that FSGS is usually severe if CMT phenotypes co-exist, it is plausible that podocytes are more susceptible to INF2 mutation-induced injury than are Schwann cells, thereby supporting the hypothesis of a lower pathogenic threshold for FSGS tha…”
BackgroundNatural History and Clinicopathological Associations of TRPC6-Associated Podocytopathy
Wooden, B., Beenken, A., Martinelli, E., Saida, K., Knob, A. L. U., Ke, J., Pisani, I., Jin, G. Y., Lane, B. M., Mitrotti, A., et al. (2024) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000501 · Cited by 18
Self-citationHereditary Podocytopathies in Adults: The Next Generation
Boyer, O., Dorval, G., & Servais, A. (2017) · Kidney Diseases · doi:10.1159/000477243 · Cited by 19
Towards precision nephrology: the opportunities and challenges of genomic medicine
Nestor, J. G., Groopman, E., & Gharavi, A. G. (2017) · Journal of Nephrology · doi:10.1007/s40620-017-0448-0 · Cited by 18
“5% of familial SRNS cases, establishing its value as part of the diagnostic evaluation for idiopathic nephrotic syndrome SNRS [39]”
BackgroundHeterozygous COL4A3 Variants in Histologically Diagnosed Focal Segmental Glomerulosclerosis
Braunisch, M. C., Büttner-Herold, M. J., Günthner, R., Satanovskij, R. M., Riedhammer, K. M., Herr, P.-M., Klein, H., Wahl, D., Küchle, C., Renders, L., et al. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00171 · Cited by 18
Treatment of nephrotic syndrome: going beyond immunosuppressive therapy
Zhao, J., & Liu, Z. (2019) · Pediatric Nephrology · doi:10.1007/s00467-019-04225-7 · Cited by 22
Potter, A. S., Drake, K. A., Brunskill, E. W., & Potter, S. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0216261 · Cited by 19
Bekheirnia, N., Glinton, K. E., Rossetti, L. Z., Manor, J., Chen, W., Lamb, D. J., Braun, M., & Bekheirnia, M. R. (2020) · Kidney360 · doi:10.34067/kid.0002272020 · Cited by 20
Current Understanding of Nephrotic Syndrome in Children
Mattoo, T. K., & Sanjad, S. A. (2022) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2022.08.002 · Cited by 17
Novel insights in the genetics of steroid-sensitive nephrotic syndrome in childhood
Dufek, S., Kleta, R., Böckenhauer, D., Gale, D. P., & Downie, M. L. (2020) · Pediatric Nephrology · doi:10.1007/s00467-020-04780-4 · Cited by 18
Trends in pediatric nephrotic syndrome
Tamura, H. (2021) · World Journal of Nephrology · doi:10.5527/wjn.v10.i5.88 · Cited by 17
Corticosteroid treatment exacerbates nephrotic syndrome in a zebrafish model of magi2a knockout
Jobst‐Schwan, T., Hoogstraten, C. A., Kolvenbach, C. M., Schmidt, J. M., Kolb, A., Eddy, K., Schneider, R., Ashraf, S., Widmeier, E., Majmundar, A. J., et al. (2019) · Kidney International · doi:10.1016/j.kint.2018.12.026 · Cited by 16
Self-citationRenal Genetics Clinic: 3-Year Experience in the Cleveland Clinic
Tan, X. Y., Borden, C., Roberts, M.-B., Mazzola, S. E., Tan, Q. K. ‐., Fatica, R. A., Simon, J. F., Calle, J., Taliercio, J. J., Dell, K. M., et al. (2022) · Kidney Medicine · doi:10.1016/j.xkme.2022.100585 · Cited by 16
Genomics in the renal clinic - translating nephrogenetics for clinical practice
Mallett, A. J., Corney, C., McCarthy, H. J., Alexander, S. I., & Healy, H. G. (2015) · Human Genomics · doi:10.1186/s40246-015-0035-1 · Cited by 16
Becherucci, F., Mazzinghi, B., Provenzano, A., Murer, L., Giglio, S., & Romagnani, P. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0315-4 · Cited by 17
“phenotype has been demonstrated to be highly informative [25, 26], very different results have been obtained when other criteria of selection have been applied [33]: this is particularly true for biopsy findings, since the pathologic pattern associated with the disease does not really distinguish between different eti…”
ResultMünch, J., Grohmann, M., Lindner, T. H., Bergmann, C., & Halbritter, J. (2016) · BMC Medical Genetics · doi:10.1186/s12881-016-0336-9 · Cited by 16
Self-citationGenetic dissection of kidney disorders
Hildebrandt, F. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.148 · Cited by 17
Self-citationMariani, L. H., & Kretzler, M. (2015) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv108 · Cited by 17
“5% of individuals, which was inversely correlated with age of onset [16].”
BackgroundYıldırım, Z. N. Y., Toksoy, G., Uyguner, Z. O., Nayır, A., Yavuz, S., Altunoğlu, U., Türkkan, Ö. N., Sevinc, B., Gökçay, G., GÜNEŞ, D. K., et al. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2019.01.011 · Cited by 16
Targeted gene therapy for rare genetic kidney diseases
Khare, V., & Cherqui, S. (2024) · Kidney International · doi:10.1016/j.kint.2024.07.034 · Cited by 15
Genetic Architecture of Childhood Kidney and Urological Diseases in China
Ye, F., Shi, H., Xiang, T., Liu, J., Liu, J., Tang, X., Fang, X., Chen, J., Zhai, Y., Shen, Q., et al. (2021) · Phenomics · doi:10.1007/s43657-021-00014-1 · Cited by 15
Krendel, M., Leh, S. M., Garone, M. E., Edwards-Richards, A., Lin, J., Brackman, D., Knappskog, P. M., & Mikhailov, A. V. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05634-x · Cited by 15
“FSGS-associated variants D388H and K604*, as well as several mutations found in patients with steroid-resistant nephrotic syndrome but without a definitive FSGS diagnosis, were identified in a large-scale sequencing survey of patients with steroid-resistant nephrotic syndrome [14].”
BackgroundModeling of ACTN4-Based Podocytopathy Using Drosophila Nephrocytes
Odenthal, J., Dittrich, S., Ludwig, V., Merz, T., Reitmeier, K., Reusch, B., Höhne, M., Cosgun, Z. C., Hohenadel, M. G., Putnik, J., et al. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.10.024 · Cited by 19
“A monogenetic form of glomerular and podocyte disorders can be detected in up to one-third of patients.(4) Genotype information is important for personalized treatment approaches because it predicts response to treatment options and risk of FSGS recurrence after transplantation, helps to avoid unnecessary drug toxicit…”
BackgroundVariability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutation
Phelan, P. J., Hall, G., Wigfall, D. R., Foreman, J. W., Nagaraj, S. K., Malone, A. F., Winn, M. P., Howell, D. N., & Gbadegesin, R. (2015) · Clinical Kidney Journal · doi:10.1093/ckj/sfv063 · Cited by 15
“who investigated 1783 families with SRNS in which they identified 208 individuals with NPHS2 mutations including 11 families (32 individuals) who were compound heterozygous for R229Q plus a pathogenic mutation [16].”
BackgroundCongenital Nephrotic Syndrome in India in the Current Era: A Multicenter Case Series
Sinha, R., Vasudevan, A., Agarwal, I., Sethi, S. K., Saha, A., Pradhan, S. K., Ekambaram, S., Thaker, N., Matnani, M., Banerjee, S., et al. (2019) · The Nephron journals/Nephron journals · doi:10.1159/000503303 · Cited by 15
Self-citationCOQ2 mutation associated isolated nephropathy in two siblings from a Chinese pedigree
Li, M., Yue, Z., Lin, H., Wang, H., Chen, H., & Sun, L. (2021) · Renal Failure · doi:10.1080/0886022x.2020.1864402 · Cited by 15
“Approximately 1% of primary steroid-resistant nephrotic syndrome (SRNS) patients were affected by genetic defects in CoQ10 synthase [6].”
BackgroundButt, L., Unnersjö‐Jess, D., Höhne, M., Hahnfeldt, R., Reilly, D., Rinschen, M. M., Plagmann, I., Diefenhardt, P., Brähler, S., Brinkkötter, P. T., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020060858 · Cited by 15
Zhu, X., Zhang, Y., Yu, Z., Li, Y., Huang, W., Sun, S., Li, Y., Wang, M., Li, Y., Sun, L., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.885178 · Cited by 15
Steroid Resistant Nephrotic Syndrome-Genetic Consideration
Tasic, V. B., Gucev, Z. S., & Polenakovic, M. H. (2015) · PRILOZI · doi:10.1515/prilozi-2015-0073 · Cited by 14
CD 80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood
Eroğlu, F. K., Orhan, D., İnözü, M., Düzova, A., Gülhan, B., Özaltın, F., & Topaloğlu, R. (2019) · Pediatrics International · doi:10.1111/ped.14005 · Cited by 15
Mitrotti, A., Giliberti, M., Leo, V. D., di Bari, I., Pontrelli, P., & Gesualdo, L. (2023) · Pediatric Nephrology · doi:10.1007/s00467-023-06046-1 · Cited by 15
“So far, approximately 60 genes have been described in association with podocytopathies and NS (Table 1), representing the main clinical sign of primary FSGS and also the second most common cause of chronic kidney disease (CKD) in children and young adults less than 25 years old [64].”
BackgroundOpportunities and Challenges of Genotyping Patients With Nephrotic Syndrome in the Genomic Era
Sampson, M. G., & Pollak, M. R. (2015) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2015.04.002 · Cited by 14
Kolvenbach, C. M., van der Ven, A. T., Kause, F., Shril, S., Scala, M., Connaughton, D. M., Mann, N., Nakayama, M., Dai, R., Kitzler, T. M., et al. (2021) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.62447 · Cited by 18
“The readouts were then filtered for most likely nonimpairing variants by assembling the sequences to the human reference genome (Sadowski et al., 2015).”
BackgroundSelf-citationHall, G., Lane, B. M., Chryst‐Ladd, M., Wu, G., Lin, J., Qin, X., Hauser, E. R., & Gbadegesin, R. (2017) · Scientific Reports · doi:10.1038/srep39933 · Cited by 15
Harita, Y. (2017) · Clinical and Experimental Nephrology · doi:10.1007/s10157-017-1449-y · Cited by 14
“8% in patients with disease manifesting during the first 3 months of life, 4–12 months, 1–6, 7–12, and 13–18 years, respectively [52, 53].”
BackgroundNarumi, K., Mishima, E., Akiyama, Y., Matsuhashi, T., Nakamichi, T., Kisu, K., Nishiyama, S., Ikenouchi, H., Kikuchi, A., Izumi, R., et al. (2017) · The Nephron journals/Nephron journals · doi:10.1159/000485109 · Cited by 14
High-Throughput Splicing Assays Identify Known and Novel WT1 Exon 9 Variants in Nephrotic Syndrome
Smith, C., Burugula, B. B., Dunn, I., Aradhya, S., Kitzman, J. O., & Yee, J. L. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.07.033 · Cited by 13
“37 Among these cohorts, we did not identify patients with any of the observed novel SDVs, potentially re fl ecting the severity of their effects as well as the genetic heterogeneity of NS.”
Effects of a novel ANLN E841K mutation associated with SRNS on podocytes and its mechanism
Lin, L., Ye, Y., Fu, H., Gu, W., Zhao, M., Sun, J., Cao, Z., Huang, G., Xie, Y., Liu, F., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01218-w · Cited by 13
“Approximately 36–50% of SRNS patients will progress to end-stage renal disease (ESRD) within 10 years [4, 5].”
BackgroundGenetic Basis of Health Disparity in Childhood Nephrotic Syndrome
Varner, J. D., Matory, A., & Gbadegesin, R. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.06.022 · Cited by 13
Molecular mechanisms determining severity in patients with Pierson syndrome
Minamikawa, S., Miwa, S., Inagaki, T., Nishiyama, K., Kaito, H., Ninchoji, T., Yamamura, T., Nagano, C., Sakakibara, N., Ishimori, S., et al. (2020) · Journal of Human Genetics · doi:10.1038/s10038-019-0715-0 · Cited by 13
Genetic Diagnosis of Rare Diseases: Past and Present
Fuentes, F. J. R., González‐Meneses, A., Ars, E., & Hernández‐Jaras, J. (2020) · Advances in Therapy · doi:10.1007/s12325-019-01176-1 · Cited by 18
Maeoka, Y., Doi, T., Aizawa, M., Miyasako, K., Hirashio, S., Masuda, Y., Kishita, Y., Okazaki, Y., Murayama, K., Imasawa, T., et al. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02040-z · Cited by 13
Zhao, B., Chen, J., Liao, Y.-B., Li, Y., Jiang, X., Bi, X., Yang, M., Li, L., & Cui, J. (2021) · Medicine · doi:10.1097/md.0000000000024627 · Cited by 13
“Diagnoses:Combinedwith clinical manifestations, laboratory testing and sequencing results, the patient was diagnosed as SRNS. Interventions: Combined intravenous methylprednisolone and cefoperazone sulbactam did not improve the patient’s condition.”
BackgroundInfluentialSinha, R., Chaudhury, A. R., Sarkar, S., Banerjee, S., Pulai, S., Dasgupta, S., Muorah, M., & Datta, D. (2022) · Kidney International Reports · doi:10.1016/j.ekir.2022.01.1047 · Cited by 13
“Data based primarily on North American and Western European population suggest that approximately a third of SRNS can be secondary to an underlying genetic etiology with podocin (NPHS2) variant being most common.(1,2) Similar data are lacking from the Indian subcontinent.”
BackgroundResultLu, L., Yap, Y.-C., Nguyen, D. Q., Chan, Y., Ng, J., Zhang, Y., Chan, C., Than, M., Liu, I. D., Asim, S., et al. (2022) · Clinical Genetics · doi:10.1111/cge.14116 · Cited by 13
“In worldwide studies, Asians accounted for a minority of the subjects.(1,7) We established the consortium “Deciphering Diversities: Renal Asian Genetics Network (DRAGoN)” in 2015.”
BackgroundJia, J., Wang, L., Ni, F.-F., Wang, M., Feng, S., Gao, X., Chan, H., Yang, X., Lee, H., Chi, H., et al. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.03.023 · Cited by 13
Genetic Syndromes Affecting Kidney Development
Pal, A., & Reidy, K. J. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_10 · Cited by 17
Need to Reclassify Etiologies of ESRD on the CMS 2728 Medical Evidence Report
Tucker, B. M., & Freedman, B. I. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08310817 · Cited by 13
Screening of the LAMB2, WT1, NPHS1, and NPHS2 Genes in Pediatric Nephrotic Syndrome
Abid, A., Shahid, S., Shakoor, M., Lanewala, A. A., Hashmi, S., & Khaliq, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00214 · Cited by 14
“7% in an International cohort (Bullich et al., 2015; Sadowski et al., 2015), 37.”
BackgroundResultInfluentialPair analysis and custom array CGH can detect a small copy number variation in COQ6 gene
Nakanishi, K., Okamoto, T., Nozu, K., Hara, S., Sato, Y., Hayashi, A., Takahashi, T., Nagano, C., Sakakibara, N., Horinouchi, T., et al. (2018) · Clinical and Experimental Nephrology · doi:10.1007/s10157-018-1682-z · Cited by 13
Li, J., Wang, L., Wan, L., Lin, T., Zhao, W., Cui, H., Li, H., Cao, L. H., Wu, J., & Zhang, T. (2019) · Pediatric Research · doi:10.1038/s41390-019-0321-z · Cited by 13
Structural features and oligomeric nature of human podocin domain
Mulukala, S. K. N., Irukuvajjula, S. S., Kumar, K., Garai, K., Venkatesu, P., Vadrevu, R., & Pasupulati, A. K. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2020.100774 · Cited by 12
“Mutations in other SD proteins such as TRPC6 and CD2AP have also been observed to cause NS but at a less frequent rate than nephrin and podocin [13 – 15].”
Gulati, A., & Somlo, S. (2017) · Pediatric Nephrology · doi:10.1007/s00467-017-3698-0 · Cited by 13
“5% of primary nephrotic syndrome in the under-25-year age group was genetically accounted for in 2015 by a panel of 27 known genes [33].”
BackgroundDirix, M., Gribouval, O., Arrondel, C., Benjelloun, S., Boyer, O., Charbit, M., Antignac, C., Heidet, L., & Dorval, G. (2023) · Clinical Genetics · doi:10.1111/cge.14305 · Cited by 15
“As such, standard genetic exploration techniques have revealed a monogenic origin in approximately 30% of patients with SRNS.(2)”
BackgroundInfluentialLaminin β2 variants associated with isolated nephropathy that impact matrix regulation
Kikkawa, Y., Hashimoto, T., Takizawa, K., Urae, S., Masuda, H., Matsunuma, M., Yamada, Y., Hamada, K., Nomizu, M., Liapis, H., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.145908 · Cited by 15
A Family Segregating Lethal Primary Coenzyme Q10 Deficiency Due to Two Novel COQ6 Variants
Wang, N., Zheng, Y., Zhang, L., Tian, X., Fang, Y., Qi, M., Du, J., Chen, S., Chen, S., Li, J., et al. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2021.811833 · Cited by 11
“Recently, large cohort studies have shown that approximately 30% of childhood-onset SRNS cases are associated with genetic defects (Sadowski et al., 2015; Wang et al., 2017; Nagano et al., 2020).”
BackgroundLéon, J., Pérez‐Sáez, M. J., Uffing, A., Murakami, N., Watanabe, A., Cureton, P., Kenyon, V., Keating, L., Yee, K., Satiro, C. A. F., et al. (2018) · Kidney International Reports · doi:10.1016/j.ekir.2018.02.011 · Cited by 15
“In a subset of SRNS, causative genetic mutations have been discovered.(1) When no genetic mutation can be found, it is hypothesized that toxic circulating factor(s) causes podocyte injury and consequently increases glomerular permeability.”
BackgroundJoshi, A. A., Sinha, A. P., Sharma, A., Shamim, U., Uppili, B., Sharma, P., Zahra, S., Parveen, S., Mathur, A., Chandan, M., et al. (2021) · Indian Pediatrics · doi:10.1007/s13312-021-2215-5 · Cited by 12
“Samples were collected from 34 unrelated patients (53% boys) with congenital NS diagnosed at 7 centers across India.”
BackgroundInfluentialBrown, B. J., Boekell, K. L., Stotter, B. R., Talbot, B. E., & Schlöndorff, J. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0272313 · Cited by 12
“Studies over the last 25 years have uncovered a substantial genetic component in the pathogenesis of FSGS [4–9].”
A review of the genetic background in complicated WT1-related disorders
Nagano, C., & Nozu, K. (2024) · Clinical and Experimental Nephrology · doi:10.1007/s10157-024-02539-x · Cited by 11
Crawford, B. D., Gillies, C. E., Robertson, C. C., Kretzler, M., Otto, E. A., Vega-Warner, V., Kang, H. M., & Sampson, M. G. (2016) · Pediatric Nephrology · doi:10.1007/s00467-016-3513-3 · Cited by 11
“The two largest published NS cohorts sequenced between 1 and 31 genes in 1,174 patients [10] and 27 genes in 2,016 patients [11].”
BackgroundSelf-citationKitzler, T. M., Kachurina, N., Bitzan, M. M., Torban, E., & Goodyer, P. (2018) · Pediatric Nephrology · doi:10.1007/s00467-018-3995-2 · Cited by 11
Unravelling the Role of PAX2 Mutation in Human Focal Segmental Glomerulosclerosis
Longaretti, L., Trionfini, P., Brizi, V., Xinaris, C., Mele, C., Breno, M., Romano, E., Giampietro, R., Remuzzi, G., Benigni, A., et al. (2021) · Biomedicines · doi:10.3390/biomedicines9121808 · Cited by 11
“Familial steroid-resistant nephrotic syndrome (SRNS) is a subgroup of nephrotic syndromes classified by genetic mapping studies that progress to end stage renal disease (ESRD) [1].”
BackgroundDownie, M. L., Gupta, S., Chan, M., Sadeghi‐Alavijeh, O., Cao, J., Parekh, R. S., Diz, C. B., Bierżyńska, A., Levine, A. P., Pepper, R. J., et al. (2022) · Pediatric Nephrology · doi:10.1007/s00467-022-05789-7 · Cited by 10
“Currently, testing for monogenic disease is recommended in patients with SRNS because pathogenic variants of podocyte-expressed genes are identifiable in 5–30% of such cases and these patients typically do not respond to intensified immunosuppression [6].”
BackgroundRetinopathy and optic atrophy in a case of COQ2 -related primary coenzyme Q 10 deficiency
Stallworth, J. Y., Blair, D. R., Slavotinek, A. M., Moore, A. T., Duncan, J. L., & Campomanes, A. G. D. A. (2022) · Ophthalmic Genetics · doi:10.1080/13816810.2022.2141792 · Cited by 11
“518 G>A variants identified in the current case; despite the same genotype, however, the patient was not reported to have any ocular pathology (although the patient was only two years old at the time of the report) (14).”
Suzuki, R., Sakakibara, N., Ichikawa, Y., Kitakado, H., Ueda, C., Tanaka, Y., Okada, E., Kondo, A., Ishiko, S., Ishimori, S., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.06.019 · Cited by 11
“Finally, we analyzed 108 patients with clinical data.(1,2,7-9,11-41)”
MethodTrachtman, H., Diva, U., Murphy, E., Wang, K., Inrig, J. K., & Komers, R. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.07.022 · Cited by 13
An inactivating human TRPC6 channel mutation without focal segmental glomerulosclerosis
Batool, L., Hariharan, K., Xu, Y., Kaßmann, M., Tsvetkov, D., Gohlke, B.-O., Kaden, S., Gossen, M., Nürnberg, B., Kurtz, A., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04901-w · Cited by 11
“Genetic linkage studies have identified at least 27 genes accountable for dominant or recessive familial FSGS forms [5].”
BackgroundMulukala, S. K. N., Nishad, R., Kolligundla, L. P., Saleem, M. A., Prabhu, N. P., & Pasupulati, A. K. (2016) · IUBMB Life · doi:10.1002/iub.1515 · Cited by 10
“Among those genes, NPHS2, encoding podocin, is the most frequently mutated gene responsible for up to 18% of total SRNS cases (9,10).”
InfluentialA novel mutation of laminin β2 (LAMB2) in two siblings with renal failure
Falix, F. A., Bennebroek, C. A. M., van der Zwaag, B., Lapid‐Gortzak, R., Florquin, S., & Oosterveld, M. J. S. (2017) · European Journal of Pediatrics · doi:10.1007/s00431-017-2871-6 · Cited by 11
“(Cys310Arg) mutation was found by mutational screening of a study population of steroid-resistant nephrotic syndrome [10], underscoring the importance of cysteines in this protein domain.”
Background
Metadata
- Authors
- Sadowski, C. E., Lovric, S., Ashraf, S., Pabst, W. L., Gee, H. Y., Kohl, S., Engelmann, S., Vega-Warner, V., Fang, H., Halbritter, J., Somers, M. J., Tan, W., Shril, S., Fessi, I., Lifton, R. P., Bockenhauer, D., El-Desoky, S., Kari, J. A., Zenker, M., Kemper, M. J., Mueller, D., Fathy, H. M., Soliman, N. A., & Hildebrandt, F.
- Affiliations
- Boston Children's Hospital (US)
- University of Michigan (US)
- Howard Hughes Medical Institute (US)
- King Abdul Aziz University Hospital (SA)
- Otto-von-Guericke-Universität Magdeburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Stiftung Charité (DE)
- Alexandria University (EG)
- Cairo University (EG)
- Corresponding author
- Sadowski, Carolin E.
- Lovric, Svjetlana
- Ashraf, Shazia
- Pabst, Werner L.
- Gee, Heon Yung
- Kohl, Stefan
- Engelmann, Susanne
- Fang, Humphrey
- Halbritter, Jan
- Somers, Michael J.
- Tan, Weizhen
- Shril, Shirlee
- Fessi, Inès
- Kemper, Markus J.
- Hildebrandt, Friedhelm
- ORCID
- Venue
- Journal of the American Society of Nephrology
- Published
- 2015-06
- Volume
- 26
- Issue
- 6
- Pages
- 1279-1289
- ISSN
- 1046-6673 (ISSN-L)
- PMC
- PMC4446877
- OpenAlex
- W2163605874
- Cited by
- 651
- References
- 41
- Citations by year
- 2026: 45 · 2025: 40 · 2024: 45 · 2023: 63 · 2022: 69 · 2021: 61 · 2020: 55 · 2019: 55 · 2018: 64 · 2017: 62 · 2016: 50 · 2015: 40
- FWCI
- 40.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Scholarship@Western (Western University) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Nephcure Foundation
- Kidney Research UK (RP45/2008)
- National Institutes of Health
- Manton Center for Orphan Disease Research, Boston Children's Hospital
- National Institute of Diabetes and Digestive and Kidney Diseases (RC4-DK076683, P30DK079310, R01DK076683)
- Topics
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Health Sciences › Medicine › Oncology › Renal and related cancers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- steroid-resistant nephrotic syndrome, NPHS2, WT1, PLCE1, coenzyme Q10 biosynthesis, age of onset, genotype-phenotype correlation, molecular genetic diagnosis, pediatric kidney disease, end-stage renal disease
- MeSH terms
- Adolescent, Adult, Child, Child, Preschool, Female, Genotype, Heterozygote, Humans, Infant, Male, Membrane Proteins, Middle Aged, Mutation, Nephrotic Syndrome, Pedigree, Phenotype, Retrospective Studies, Cohort Studies, Incidence, Genes, Wilms Tumor, Age of Onset, Risk Assessment, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins, Young Adult, Genetic Association Studies, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.